ERDERA BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe September 18, 2024
BEAMER BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe November 9, 2021
EURO-NMD Registry Hub EURO-NMD, ERN for Rare Neuromuscular Diseases, spans 14 European countries, with 61 reference centres that oversee more than 100,000 patients.… July 2, 2020
FAIR Data Declaration The World Duchenne Organization and several of its members have been advocating for better use of Duchenne data, which is… January 7, 2020
BIND First project of this scale to improve characterisation of brain involvement in Duchenne and Becker Muscular Dystrophy November 27, 2019
VISION-DMD VISION-DMD is a collaborative global project aiming to develop a safe, effective and affordable therapy for Duchenne Muscular Dystrophy (DMD).… November 8, 2019
Share4Rare A rare disease affects less than 5 in 10.000 persons, and the 50% of them are children. Keeping this number… November 8, 2019
Trials@Home The Trials@Home consortium is exploring the opportunities of moving clinical trials from the traditional clinic setting to the participant's immediate… November 3, 2019